NanoString Technologies Garners $15,300,000 Series E Financing Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=8776366a-1e7d-414e-8a32-b05ab0cf6472&Preview=1 -
Date
12/3/2012 -
Company Name
NanoString Technologies -
Mailing Address
530 Fairview Ave N Seattle, WA 98109 -
Company Description
NanoString Technologies is developing a patent pending platform for single molecule identification and digital quantification. The NanoString system uniquely barcodes individual target molecules, scans them, and delivers a literal inventory of target molecules in the biological sample. -
Website
http://www.nanostring.com -
Transaction Type
Venture Equity -
Transaction Amount
$15,300,000 -
Transaction Round
Series E -
Proceeds Purposes
The proceeds of the financing will be used to support the expansion of NanoString’s existing life sciences business and its first commercial launch in molecular diagnostics. -
M&A Terms
-
Venture Investor
Morgan Stanley Expansion Capital -
Venture Investor
AllianceBernstein -
Venture Investor
Clarus Ventures -
Venture Investor
Draper Fisher Jurvetson -
Venture Investor
OVP Venture Partners -
Venture Investor
GE Healthymagination Fund -
Venture Investor
BioMed Ventures -
Venture Investor
Individual Investor
